瑞普生物

- 300119

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011  2010 
瑞普生物(300119) 利润表
单位:万元
报表日期2020-03-312019-12-312019-09-302019-06-302019-03-31
一、营业总收入45,392.20146,658.05103,312.2565,345.0030,741.70
营业收入45,392.20146,658.05103,312.2565,345.0030,741.70
二、营业总成本35,681.82125,580.6785,268.3453,967.3725,699.47
营业成本19,536.8969,915.8749,886.3932,393.5415,308.89
营业税金及附加382.231,782.371,245.99794.30348.33
销售费用8,949.3827,944.3117,265.0510,350.543,942.93
管理费用4,113.3914,135.288,727.675,223.062,621.90
财务费用827.482,323.601,588.751,041.00517.23
研发费用1,872.439,479.246,554.514,164.931,909.96
资产减值损失--------1,050.23
公允价值变动收益620.526,821.76------
投资收益8.261,502.451,558.89957.91524.62
其中:对联营企业和合营企业的投资收益0.06-139.57-55.69-30.25-31.97
汇兑收益----------
三、营业利润9,914.0326,306.7420,013.2812,005.776,068.52
加:营业外收入8.68191.87135.2458.038.19
减:营业外支出78.90506.9795.0947.4612.34
其中:非流动资产处置损失----------
四、利润总额9,843.8125,991.6420,053.4212,016.346,064.37
减:所得税费用1,375.523,611.772,760.071,532.92859.82
五、净利润8,468.2822,379.8617,293.3510,483.425,204.55
归属于母公司所有者的净利润7,312.8619,435.9914,465.328,634.194,329.24
少数股东损益1,155.422,943.872,828.041,849.23875.31
六、每股收益
基本每股收益(元/股)0.18520.48940.36360.21620.1076
稀释每股收益(元/股)0.18520.48940.36360.21620.1076
七、其他综合收益----------
八、综合收益总额8,468.2822,379.8617,293.3510,483.425,204.55
归属于母公司所有者的综合收益总额7,312.8619,435.9914,465.328,634.194,329.24
归属于少数股东的综合收益总额1,155.422,943.872,828.041,849.23875.31
下载全部历史数据到excel中 返回页顶